Jiang, Xizi
XU, Yitong
Ren, Hongjiu
Jiang, Jun
Wudu, Muli
Wang, Qiongzi
Guan, Jingqian
Su, Hongbo
Zhang, Yao
Zhang, Bo
Guo, Yuanzi
Hu, Yujiao
Jiang, Lihong
Liu, Zongang
Wang, Huanxi
Cheng, Yu
Sun, Limei
Qiu, Xueshan
Funding for this research was provided by:
Natural Science Foundation of Liaoning Province (2019-MS-03)
Key Technologies Research and Development Program (Molecular mechanism of KLHL18 inhibiting proliferation of lung cancer cells by MEK/ERK)
Article History
Received: 12 August 2020
Accepted: 17 November 2020
First Online: 27 November 2020
Ethics approval and consent to participate
: This study was approved by the Medical Research Ethics Committee of China Medical University.
: All recruited patients provided informed consent.
: The authors declare that they have no competing interests.